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The present study was conducted to determine the antibiotic susceptibility pattern of Pseudomonas aeruginosa
from sputum samples of lower respiratory tract infection patients admitted to different hospitals of Karachi. Most of
the hospitals are hampered with high frequency of nosocomial infections generally caused by multiresistant
nosocomial pathogen. Among Gram-negative pathogens Pseudomonas aeruginosa considered as most challenging
pathogen. The objective of the study was to determine frequency of Pseudomonas aeruginosa from sputum
samples and to find out susceptibility pattern against four antibiotics widely used for treatment. The sputum
samples from 498 patients were collected consecutively between January 2010 and March 2011 and were cultured
and identified. According to CLSI (Clinical Laboratory Standards Institute) guidelines antimicrobial susceptibility
testing was performed by disc diffusion method. Pseudomonas aeruginosa were isolated from 24% (120/498) of the
lower respiratory tract patient. A higher resistance to Pseudomonas aeruginosa isolate was observed with
piperacillin/tazobactam and cefipime i.e. 42% and 40% respectively. Imipenem was found to be most effective
antibiotic against Pseudomonas aeruginosa (76% sensitivity) but amikacin resistance was continuously increasing. In
conclusion the frequency of Pseudomonas aeruginosa was also higher among lower respiratory tract infection
patients with alarmingly high rate of resistance among widely used antibiotics. These findings focused on careful
consideration for monitoring and optimization of antimicrobial use in order to reduce occurrence and spread of
antimicrobial resistant pathogen.Introduction
In general practice bronchitis and pneumonia were most
common lower respiratory tract infections and were
related to considerable mortality and morbidity world-
wide (Macfarlane et al. 2001). According to statistics
4.4% of hospital admissions and 6% of general practi-
tioner consultations were related to lower respiratory
tract infections (Anderson et al. 1993). A wide variety of
antimicrobial agents with anti-pseudomonal activity
along with advancement in medical and surgical care
has been developed but Pseudomonas aeruginosa
causing life threatening infections continue to cause
complications in hospitals acquired infections (Mayhall
1996). Pseudomonas aeruginosa is a Gram-negative
aerobic rod belong to family Pseudomonadaceae. It* Correspondence: anabfatima@hotmail.com
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major cause of nosocomial infections. It was also consid-
ered as most challenging pathogen globally because of
its high rate of resistance to antimicrobial agents (Hugbo
and Olurinola 1992; Trilla 1994). The Pseudomonas aer-
uginosa had very minimal nutritional requirement that
expedited its growth in hospital environment (Gilligan
1995). Resistance to multiple antimicrobial agents dis-
played by Pseudomonas aeruginosa and only few
antibiotics found to be effective against Pseudomonas
aeruginosa (Carmeli et al. 1999). A high resistance
pattern of Pseudomonas aeruginosa measured as cause
of higher mortality rate by Pseudomanal infections
(Samporn et al. 2004). Different geographical locations
and hospital environments showed variation in suscepti-
bility pattern of Pseudomonas aeruginosa isolates
therefore idiosyncrasy of isolate susceptibility patternn Open Access article distributed under the terms of the Creative Commons






Figure 1 % occurrence of lower respiratory tract infections in
males and females by Pseudomonas aeruginosa.
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nal infections for better achievement of results.
In this study we aimed to determine the prevalence of
Pseudomonas aeruginosa in lower respiractory tract in-




A total number of 498 sputum samples were collected
from adult patients attended/admitted in pulmonary de-
partment of various hospitals and clinics suffered from
lower respiratory tract infections in 14 months period
from January 2010 to March 2011. Out of 498 samples
120 samples were Pseudomonas aeruginosa.
Microbiology/sample processing
The samples were transferred to microbiology laboratory
and were analyzed within 30 min to 1 hour of collection.
Nutrient agar, MacConkey agar and blood agar (Oxoid
UK) used for streaking of sample and then incubated at
37°C for 24 hours as described by chessborough (Chees-
borough 2002). After incubation Pseudomonas isolation
agar media (Oxoid UK) used for sub-culturing of isolate
obtained. The pure isolates of Pseudomonas aeruginosa
were transferred to 1% nutrient agar slant and stored in
the refrigerator at 4 ± 1°C. Diifferent identification tests
were performed on suspected Pseudomonas aeruginosa
and were characterized and identified i.e. Gram-stain,
colonial morphology, positive oxidase reaction, produc-
tion of pyocyanin on Mueller-Hinton agar (Oxoid UK),
citrate utilization and growth at 42°C.
Antibiotic susceptibility test
By disk diffusion technique antibiotic susceptibility pat-
tern of isolates on commonly used antibiotics was per-
formed on Mueller-Hinton agar medium according to
Clinical Laboratory Standard Institute (CLSI) guidelines
(NCCLS 1995). Paper disk were impregnated with anti-
biotics (Sigma chemicals): imipenem (10 μg), Amikacin
(30 μg), piperacillin / tazobactam (100/10 μg) and cefi-
pime (30 μg) respectively and incubated at 37°C for
24 hours in 5–10% CO2 enriched environment. The
medium containing antibiotic disks were quality con-
trolled daily by standard culture. After defined incuba-
tion period the diameter of zone of inhibition was
measured and interpretation of result based on CLSI
guidelines was performed (NCCLS 1995).
Result
In 14 months period a total of 498 sputum specimens
were collected consecutively from different hospitals of
Karachi and a total of 120 Pseudomonas aeruginosa
strains (24%) were isolated of which 85 samples (70.8%)and 35 samples (29.1%) were reported from males and
females respectively (Figure 1).
The antibiotic resistance pattern of isolates presented
in Figure 2. The most effective antibiotic was from Car-
bapenem i.e. imipenem and its resistance rate was
detected as 24%.
Piperacillin/tazobactam and cefipime showed more re-
sistance i.e. 42% and 40% respectively. Amikacin also
showed 35% resistance. Graphically Figure 2 clearly re-
flect antibiotic susceptibility profile of Pseudomonas aer-
uginosa isolates and showed that imipenem was most
sensitive then all other antibiotics used.Discussion
The main objective of this study was to investigate epi-
demiological data of Pseudomonas aeruginosa strains in
lower respiratory tract infection patients and to deter-
mine the antimicrobial resistance pattern of bacteria
against some commonly used antibiotics. The predomin-
ance of Pseudomonas aeruginosa resistance considered
as serious problem in many countries (Agarwal et al.
2006; Ako-Nai et al. 2006; Balkhy et al. 2006; Lizioli
et al. 2003). It was also reported that Pseudomonas aeru-
ginosa is one of the most common nosocomial pathogen
and a leading cause of nosocomial respiratory tract in-
fection (Gilligan 1995; Jarvis and Martone 1992; Jarlier
et al. 1996).
From previous literature high rate of resistance against
carbapenem, quinolones and third generation cephalo-
sporin had been detected in Pseudomonas aeruginosa
(Hancock 1998; Quinn 1998; Sader et al. 1998). In our
study resistance rate against imipenem from carbapenem
group was determined as 24% which was considerably
accelerating towards higher side in Pakistan and this was
in agreement with previous study conducted by Akhtar
N which showed resistance rate of 26.1% (Akhtar 2010).
It was reported that resistance to imipenem was 14% in
Spain (Bouza et al. 1999), 19.3% in Italy (Bonfiglio et al.


















Figure 2 Resistance rate of Pseudomonas aeruginosa. IMP:
imipenem, AMIK: amikacin, PIP/TAZO: piperacillin/tazobactam, CFP:
cefipime.
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Pseudomonas aeruginosa was only 5–9% against amika-
cin (Bouza et al. 1999; Gerding et al. 1991). In the
present study the rate of amikacin resistance was found
to be relatively high i.e. 35% however it may in accord-
ance with Friedland et al. who reported that amikacin
resistance related to more intensive usage of amino gly-
cosides (Friedland et al. 1992). The increasing rate of
amikacin in Pakistan was also reported by Akhtar N i.e.
21.3 against Pseudomonas aeruginosa (Akhtar 2010). It
was further investigated that when amikacin used in
combination with impenem i.e. as combination therapy
resistance rate among Pseudomonas aeruginosa was
reduced to 10% (Bustamante et al. 1987).
Piperacillin/tazobactam resistance rate was 7% in a na-
tionwide in Spain (Bouza et al. 1999). Contrary to this
resistance rate in isolates was higher in our study (42%).
In a previous study equivalent safety and efficacy of
intravenous Piperacillin/tazobactam with intravenous
imipenem/cilastatin was reported for intra-abdominal
infections caused by Pseudomonas aeruginosa but pres-
ently resistance was different for both antibiotics which
might be due to extensive usage of this combination in
our hospitals as life saving antibiotics (Erasmo et al.
2004).
In the present study resistance rate of Pseudomonas
aeruginosa against cefepime observed was deviated from
reported data as it showed 40% resistance while in previ-
ous reported data it did not exceed 17% (Bouza et al.
1999).
The data obtained from our study in Pakistan it was
probable that application of conventional agents for the
empirical treatment become complicated by the respira-
tory pathogens with accelerating resistance to antibio-
tics. Therefore for an effective management of lowerrespiratory tract infection an ultimate and detailed bac-
teriological diagnosis and susceptibility testing required
to overcome global problem of antibiotic resistance
and by encouraging greater understanding of this prob-
lem different solutions can be planned by health care
providers.
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